LOH analysis should not be used as a tool to assess whether UVs of BRCA1/2 are pathogenic or not

被引：10

作者：

Beristain, E. ^{[1
]}

Guerra, I. ^{[2
]}

Vidaurrazaga, N. ^{[3
]}

Burgos-Bretones, J. ^{[3
]}

Tejada, M. I. ^{[1
]}

机构：

[1] Hosp Cruces, Mol Genet Lab, Dept Biochem, Baracaldo 48903, Bizkaia, Spain

[2] Hosp Txagorritxu, Dept Pathol, Vitoria, Spain

[3] Hosp Cruces, Dept Pathol Serv, Baracaldo, Spain

来源：

FAMILIAL CANCER | 2010年 / 9卷 / 03期

关键词：

DNA-SEQUENCE VARIANTS; BREAST-CANCER; CLASSIFICATION; POPULATION;

D O I：

10.1007/s10689-009-9318-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：289 / 290

页数：2

共 8 条

[1]

[Anonymous], Breast Cancer Information Core

[2] Differences in the frequency and distribution of BRCA1 and BRCA2 mutations in breast/ovarian cancer cases from the Basque country with respect to the Spanish population:: Implications for genetic counselling [J].

Beristain, E. ;

Martinez-Bouzas, C. ;

Guerra, I. ;

Viguera, N. ;

Moreno, J. ;

Ibanez, E. ;

Diez, J. ;

Rodriguez, F. ;

Mallabiabarrena, G. ;

Lujan, S. ;

Gorostiaga, J. ;

De Pablo, J. L. ;

Mendizabal, J. L. ;

Tejada, M. I. .

BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 (02) :255-262

[3] Is early onset breast cancer with no family history a good criterion for testing BRCA1 and BRCA2 genes? A small population-based study [J].

Beristain, E. ;

Martinez-Bouzas, C. ;

Mallabiabarrena, G. ;

Tejada, M. I. .

CLINICAL GENETICS, 2009, 75 (06) :576-578

[4] Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance [J].

Chenevix-Trench, G ;

Healey, S ;

Lakhani, S ;

Waring, P ;

Cummings, M ;

Brinkworth, R ;

Deffenbaugh, AM ;

Burbidge, LA ;

Pruss, D ;

Judkins, T ;

Scholl, T ;

Bekessy, A ;

Marsh, A ;

Lovelock, P ;

Wong, M ;

Tesoriero, A ;

Renard, H ;

Southey, M ;

Hopper, JL ;

Yannoukakos, K ;

Brown, M ;

Easton, D ;

Tavtigian, SV ;

Goldgars, D ;

Spurdle, AB .

CANCER RESEARCH, 2006, 66 (04) :2019-2027

[5] Methylation not a frequent "second hit" in tumors with germline BRCA mutations [J].

Dworkin, Amy M. ;

Spearman, Andrew D. ;

Tseng, Stephanie Y. ;

Sweet, Kevin ;

Toland, Amanda Ewart .

FAMILIAL CANCER, 2009, 8 (04) :339-346

[6] Classification of missense variants of unknown significance in BRCA1 based on clinical and tumor information [J].

Osorio, A. ;

Milne, R. L. ;

Honrado, E. ;

Barroso, A. ;

Diez, O. ;

Salazar, R. ;

de la Floya, M. ;

Vega, A. ;

Benitez, J. .

HUMAN MUTATION, 2007, 28 (05) :477-485

[7] Loss of heterozygosity analysis at the BRCA loci in tumor samples from patients with familial breast cancer [J].

Osorio, A ;

de la Hoya, M ;

Rodríguez-López, R ;

Martínez-Ramírez, A ;

Cazorla, A ;

Granizo, JJ ;

Esteller, M ;

Rivas, C ;

Caldés, T ;

Benítez, J .

INTERNATIONAL JOURNAL OF CANCER, 2002, 99 (02) :305-309

[8] Clinical classification of BRCA1 and BRCA2 DNA sequence variants:: The value of cytokeratin profiles and evolutionary analysis -: A report from the kConFab investigators [J].

Spurdle, Amanda B. ;

Lakhani, Sunil R. ;

Healey, Sue ;

Parry, Suzanne ;

Da Silva, Leonard M. ;

Brinkworth, Ross ;

Hopper, John L. ;

Brown, Melissa A. ;

Babikyan, Davit ;

Chenevix-Trench, Georgia ;

Tavtigian, Sean V. ;

Goldgar, David E. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (10) :1657-1663

← 1 →